載入...
Bindarit inhibits human coronary artery smooth muscle cell proliferation, migration and phenotypic switching.
Bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs) synthesis, reduces neointimal formation in animal models of vascular injury and recently has been shown to inhibit in-stent late loss in a placebo-controlled phase II clinical trial. However, the mechanisms underlying the effica...
Na minha lista:
Main Authors: | , , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science (PLoS)
2012-01-01
|
叢編: | PLoS ONE |
在線閱讀: | http://europepmc.org/articles/PMC3471825?pdf=render |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|